# Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

> **NCT03351348** · PHASE3 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 165 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Bupivacaine
- **BEHAVIORAL:** patient-reported pain scores
- **OTHER:** saline

## Key facts

- **NCT ID:** NCT03351348
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-11-16
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2025-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03351348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03351348, "Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03351348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*